Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:120 |
|---|---|
| Enthalten in: |
Cardiovascular research - 120(2024), 2 vom: 13. März, Seite 111-113 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Masson, David [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
25167-62-8 |
|---|
| Anmerkungen: |
Date Completed 14.03.2024 Date Revised 20.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cvr/cvae007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366841793 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366841793 | ||
| 003 | DE-627 | ||
| 005 | 20240320233921.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cvr/cvae007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM366841793 | ||
| 035 | |a (NLM)38193579 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Masson, David |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2024 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Eicosapentaenoic Acid |2 NLM | |
| 650 | 7 | |a AAN7QOV9EA |2 NLM | |
| 650 | 7 | |a Fatty Acids, Omega-3 |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Docosahexaenoic Acids |2 NLM | |
| 650 | 7 | |a 25167-62-8 |2 NLM | |
| 700 | 1 | |a Leleu, Damien |e verfasserin |4 aut | |
| 700 | 1 | |a Farnier, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Chagué, Fréderic |e verfasserin |4 aut | |
| 700 | 1 | |a Rampon, Chloé |e verfasserin |4 aut | |
| 700 | 1 | |a Bichat, Florence |e verfasserin |4 aut | |
| 700 | 1 | |a Demeule, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Maza, Maud |e verfasserin |4 aut | |
| 700 | 1 | |a Pais de Barros, Jean-Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Cottin, Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Zeller, Marianne |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular research |d 1967 |g 120(2024), 2 vom: 13. März, Seite 111-113 |w (DE-627)NLM000080209 |x 1755-3245 |7 nnns |
| 773 | 1 | 8 | |g volume:120 |g year:2024 |g number:2 |g day:13 |g month:03 |g pages:111-113 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cvr/cvae007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 120 |j 2024 |e 2 |b 13 |c 03 |h 111-113 | ||